Hijal
Barringtonia acutangula
Barringtonia acutangula, a plant native to Southeast Asia and parts of the Pacific Islands, has not been traditionally used for medicinal purposes. Scientific research indicates potential health benefits; aqueous extracts from its flowers exhibit higher antioxidant activity and inhibit α-glucosidase, suggesting possible anti-diabetic effects. Additionally, topical gels containing fruit extract show significant wound healing activity in rats, though more studies are needed to confirm these findings. In vitro and in vivo experiments suggest that compounds from Barringtonia angusta can suppress inflammatory responses by targeting the Src/NF-κB signaling pathway. Safety profiles for this plant appear favorable with no major issues recorded; however, comprehensive clinical trials are still lacking. There is currently no evidence of significant drug interactions, but further investigation is warranted to fully understand its potential effects and interactions.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- A novel actinomycete species, Actinomadura barringtoniae sp. nov., was isolated from Barringtonia acutangula roots.
- Aqueous extracts of Barringtonia acutangula flowers showed higher antioxidant activity and α-glucosidase inhibition compared to other solvents.
- Topical herbal gels containing Barringtonia acutangula fruit extract showed significant wound healing activity in rats compared to untreated and reference groups.
- Ba-ME from Barringtonia angusta showed dose-dependent suppression of inflammatory responses by targeting the Src/NF-κB signaling pathway in vitro and in vivo.
Frequently asked questions
What is Hijal?
Hijal (Barringtonia acutangula) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Hijal?
4 sourced findings are recorded for Hijal; the strongest carries evidence grade D. For example: A novel actinomycete species, Actinomadura barringtoniae sp. nov., was isolated from Barringtonia acutangula roots.
How strong is the evidence for Hijal?
The strongest finding for Hijal carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Hijal safe? What are the side effects?
No major safety issues are recorded for Hijal in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Hijal interact with medications?
No drug interactions are recorded for Hijal in our sources. This does not rule them out — check with a pharmacist.
Is Hijal a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Actinomadura barringtoniae sp. nov., an endophytic actinomycete isolated from the roots of Barringtonia acutangula (L.) Gaertn. literature abstract metadata
- T2 Anti-inflammatory effect of Barringtonia angusta methanol extract is mediated by targeting of Src in the NF-κB signalling pathway. literature abstract metadata
- T2 Wound Healing Activity of Topical Herbal Gels Containing Barringtonia acutangula Fruit Extract: In silico and In vivo Studies. literature abstract metadata
- T2 Effect of different solvents on bioactive phenolics and antioxidant, antimicrobial, and α-glucosidase inhibition activities of Barringtonia acutangula Gaertn. flower extracts. literature abstract metadata